Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 23 Jun 2026 for Agios Pharmaceuticals, INC.. Read the official filing
Filing timeline
BuySaleJacqualyn A. Fouse
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jacqualyn A. Fouse: trading record in brief
Jacqualyn A. Fouse is a declared insider at 4 companies (chief executive); the most frequent names are Agios Pharmaceuticals, Inc., Incyte Corp and Madrigal Pharmaceuticals, Inc. In total, 31 filings cover trades dated from 12 February 2016 to 18 June 2026.
The open-market record consists of 1 sale worth €176k, with no purchase. The rest of the record consists of 18 share grants and 12 option exercises.
The latest filing, published on 23 June 2026, reports an option exercise in Agios Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jacqualyn A. Fouse
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
2,816 sharesCommon stockSEC:0001439222-26-000101:0
454 sharesCommon StockSEC:0001628280-26-044325:0
1,642 sharesCommon StockSEC:0001405288-26-000006:0
203 shares0Common StockSEC:0001628280-25-032855:0
2,120 shares0Common stockSEC:0001439222-25-000055:0
2,518 shares0Common StockSEC:0001628280-25-031013:0
15,933 shares0Common stockSEC:0001439222-25-000029:0
894 shares0Common StockSEC:0001628280-25-012364:0
3,388 shares0Common stockSEC:0001439222-24-000089:0
2,830 shares0Common StockSEC:0000879169-24-000096:0
15,934 shares0Common stockSEC:0001439222-24-000063:0
23,900 shares0Common stockSEC:0001439222-24-000016:0
17,500 shares0Common stockSEC:0001439222-24-000008:0
8,391 shares@ US$22.99100.0% of flowCommon stockSEC:0001439222-24-000008:1
23,900 shares0Common stockSEC:0001439222-23-000107:0
2,505 shares0Common StockSEC:0001209191-23-037797:0
15,933 shares0Common stockSEC:0001439222-23-000059:0
11,333 shares0Common stockSEC:0001439222-23-000024:0
252 shares@ US$80.3210.4% of flowCommon StockSEC:0001209191-23-000801:0
291 shares@ US$66.6410.8% of flowCommon StockSEC:0001209191-22-052164:0
275 shares@ US$75.970.0001% mcap13.9% of flowCommon StockSEC:0001209191-22-040182:0
2,144 shares0Common StockSEC:0001209191-22-037800:0
280 shares@ US$79.420.0001% mcap14.0% of flowCommon StockSEC:0001209191-22-022293:0
12,379 shares0Common stockSEC:0001439222-22-000017:0
11,334 shares0Common stockSEC:0001439222-22-000012:0
25 of 31 declarations
